technetium has been researched along with Cortical Lewy Body Disease in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Honda, G; Iida, H; Kawasaki, H; Kuwabara, Y; Nagamachi, S; Nonokuma, M; Ogomori, K; Takano, K; Tsuboi, Y; Yoshimitsu, K | 1 |
| Blankenberg, FG; Gilad, R; Lampl, Y; Lorberboym, M; Sadeh, M | 1 |
| Burn, DJ; Colloby, SJ; Firbank, MJ; McKeith, IG; O'Brien, JT; Owens, J; Pakrasi, S; Perry, EK; Piggott, MA; Williams, ED; Wyper, DJ | 1 |
3 other study(ies) available for technetium and Cortical Lewy Body Disease
| Article | Year |
|---|---|
The development of new method to differentiate between Dementia with Lewy bodies and Alzheimer's disease by cerebral perfusion SPECT-comparison to CIScore.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Diagnosis, Differential; Female; Humans; Lewy Body Disease; Technetium; Tomography, Emission-Computed, Single-Photon | 2021 |
Annexin V SPECT imaging of phosphatidylserine expression in patients with dementia.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Annexin A5; Dementia; Dementia, Vascular; Female; Humans; Hydrazines; Injections, Intravenous; Lewy Body Disease; Ligands; Magnetic Resonance Imaging; Male; Middle Aged; Nicotinic Acids; Phosphatidylserines; Pilot Projects; Technetium; Tomography, Emission-Computed, Single-Photon | 2006 |
In vivo SPECT imaging of muscarinic acetylcholine receptors using (R,R) 123I-QNB in dementia with Lewy bodies and Parkinson's disease dementia.
Topics: Aged; Female; Humans; Image Processing, Computer-Assisted; Iodine Radioisotopes; Lewy Body Disease; Male; Middle Aged; Parkinson Disease; Quinuclidinyl Benzilate; Reference Values; Technetium; Tomography, Emission-Computed, Single-Photon | 2006 |